A Review About Pembrolizumab in First-Line Treatment of Advanced NSCLC: Focus on KEYNOTE Studies

Qu J, Wang L, Jiang M, Zhao D, Wang Y, Zhang F, Li J, Zhang X

Cancer Management and Research 2020, 12:6493-6509

Published Date: 28 July 2020